-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
On September 9, the launch ceremony for the 5G Industrial Internet Project of Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ) was held with great fanfare. The project is jointly developed by Keyuan Pharmaceutical and China Telecom, focusing on building a dedicated 5G industrial private network infrastructure to lay a solid digital foundation for comprehensively advancing digital and intelligent transformation and upgrading, and striving to establish a benchmark case of 5G-plus smart manufacturing in the pharmaceutical and chemical industries.
2026-09-09
To fulfill its corporate social responsibility and support the development of education, on August 14, Shandong Keyuan Pharmaceutical Co.,Ltd. (stock code: 301281.SZ), through its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., visited the vocational secondary school campus of Licheng No. 2 Middle School to carry out a heartwarming educational assistance donation event, donating summer relief supplies to the Jinan Licheng Charity Federation and Licheng Vocational Secondary School.
2026-08-14
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline